Immunotherapeutics in lung cancers: from mechanistic insight to clinical implications and synergistic perspectives

被引:0
|
作者
Hardeep Singh Tuli
Vivek K. Garg
Renuka Choudhary
Ashif Iqubal
Katrin Sak
Adesh K. Saini
Reena V. Saini
Kanupriya Vashishth
Kuldeep Dhama
Ranjan K. Mohapatra
Dhruv Sanjay Gupta
Ginpreet Kaur
机构
[1] Maharishi Markandeshwar Engineering College,Department of Biotechnology
[2] Maharishi Markandeshwar (Deemed to Be University),Department of Medical Lab Technology
[3] University Institute of Applied Health Sciences,Department of Pharmacology, School of Pharmaceutical Education and Research (Formerly, Faculty of Pharmacy)
[4] Chandigarh University,Advance Cardiac Centre Department of Cardiology
[5] Jamia Hamdard (Deemed to Be University),Division of Pathology
[6] NGO Praeventio,Department of Chemistry
[7] Post Graduate Institute of Medical Education and Research (PGIMER),Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management
[8] ICAR-Indian Veterinary Research Institute,undefined
[9] Government College of Engineering,undefined
[10] SVKM’s NMIMS,undefined
来源
Molecular Biology Reports | 2023年 / 50卷
关键词
Lung cancer; Immunotherapeutic; Clinical trials; Chemotherapeutics; Radiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2685 / 2700
页数:15
相关论文
共 50 条
  • [41] BRAF inhibitor-associated cutaneous squamous cell carcinoma: new mechanistic insight, emerging evidence for viral involvement and perspectives on clinical management
    Wu, J. H.
    Cohen, D. N.
    Rady, P. L.
    Tyring, S. K.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (04) : 914 - 923
  • [42] Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision-making
    Ankolekar, Anshu
    van der Heijden, Britt
    Dekker, Andre
    Roumen, Cheryl
    De Ruysscher, Dirk
    Reymen, Bart
    Berlanga, Adriana
    Oberije, Cary
    Fijten, Rianne
    HEALTH EXPECTATIONS, 2022, 25 (04) : 1342 - 1351
  • [43] Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications
    Zito Marino, Federica
    Bianco, Roberto
    Accardol, Marina
    Ronchi, Andrea
    Cozzolino, Immacolata
    Morgillo, Floriana
    Rossi, Giulio
    Franco, Renato
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (07): : 981 - 989
  • [44] Access to Care for Childhood Cancers in India: Perspectives from Health Care Providers and the Implications for Universal Health Coverage
    Faruqui, N.
    Bernays, S.
    Martiniuk, A.
    Abimbola, S.
    Arora, R.
    Lowe, J.
    Denburg, A.
    Joshi, R.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S45 - S46
  • [45] Safety Implications of Modulating Nuclear Receptors: A Comprehensive Analysis from Non-Clinical and Clinical Perspectives
    Rao, Mohan
    Mcduffie, Eric
    Srivastava, Sanjay
    Plaisted, Warren
    Sachs, Clifford
    PHARMACEUTICALS, 2024, 17 (07)
  • [46] Evidence that neck metastasis from occult SCC are virus associated cancers. Clinical implications
    Bussu, F.
    Micciche, F.
    Dinapoli, N.
    Autorino, R.
    Balducci, M.
    Parrilla, C.
    Galli, J.
    Almadori, G.
    Paludetti, G.
    Valentini, V.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S22 - S23
  • [47] Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
    Mantik, Keren Esther Kristina
    Kim, Sujin
    Gu, Bonsang
    Moon, Sohee
    Kwak, Hyo-Bum
    Park, Dong-Ho
    Kang, Ju-Hee
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [48] Berberine: A multifaceted agent for lung cancer treatment-from molecular insight to clinical applications
    Xu, Xiaodan
    He, Yuanyuan
    Liu, Jungang
    GENE, 2025, 934
  • [49] Growing health concerns from perfluoroalkyl substances: public health perspectives and clinical implications
    Anderko, Laura
    PEDIATRIC RESEARCH, 2020, 87 (06) : 980 - 981
  • [50] Growing health concerns from perfluoroalkyl substances: public health perspectives and clinical implications
    Laura Anderko
    Pediatric Research, 2020, 87 : 980 - 981